Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-022206
Filing Date
2026-07-01
Accepted
2026-07-01 06:01:30
Documents
10
Period of Report
2026-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K athe20260701_6k.htm 6-K 10825
2 EXHIBIT 99.1 ex_983540.htm EX-99.1 4362
3 a01.jpg GRAPHIC 80715
4 a02.jpg GRAPHIC 63710
5 a03.jpg GRAPHIC 54003
6 a04.jpg GRAPHIC 147833
7 a05.jpg GRAPHIC 61182
8 a06.jpg GRAPHIC 30470
9 a07.jpg GRAPHIC 166706
10 a08.jpg GRAPHIC 46071
  Complete submission text file 0001437749-26-022206.txt   911933
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 261142438
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)